首页> 外文OA文献 >Synthesis, characterization and anthelmintic activity evaluation of pyrimidine derivatives bearing carboxamide and sulphonamide moieties
【2h】

Synthesis, characterization and anthelmintic activity evaluation of pyrimidine derivatives bearing carboxamide and sulphonamide moieties

机译:甲酰胺衍生物携带羧酰胺和磺酰胺部分的合成,表征和致力学活性评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Pyrimidines, sulphonamides and carboxamides have shown a large number of pharmacological properties against different types of diseases including helminthiasis. Seventeen new pyrimidine derivatives bearing sulphonamide and carboxamide were synthesized and investigated for their in vitro anthelmintic properties. Substituted benzenesulphonyl chlorides 15a–c were treated with various amino acids (16a–h) to obtain benzenesulphonamide derivatives 17a–l. Compounds 17a–f were subsequently treated with benzoyl chloride to obtain the N-benzoylated derivatives 19a–f. Further reactions of compounds 19a–f and 17g–l with 4- or 2-aminopyrimidine (20) using boric acid as a catalyst gave the required sulphonamide carboxamide derivatives 21a–q in excellent yields. The compounds were isolated in their analytical grade and characterized using FTIR, 1H-NMR, 13C-NMR and HRMS. The in vitro anthelmintic studies showed that all the synthesized compounds possessed anthelmintic property. Compounds 21a–c, e, g, m and p showed mean paralyzing times of 15, 19, 14, 18, 19, 19 and 18 min, respectively, at 100 mg mL-1 compared to 10 min for albendazole. Compounds 21a–c, g and m had mean death times of 18, 24, 16, 20 and 25 min, respectively, at 100 mg mL-1 compared to 13 min for albendazole.
机译:嘧啶,磺胺和羧酰胺都表现出了大量针对不同类型的疾病,包括蠕虫病的药理学性质的。 17个新的嘧啶衍生物轴承磺酰胺和羧酰胺的合成和研究了其在体外驱虫特性。替补苯磺酰氯化物15A-C分别与各种氨基酸(16A-H),得到苯磺酰胺衍生物17A-1处理。化合物17A-F,随后用苯甲酰氯处理得到的N苯甲酰衍生物19A-F。与4-或2-氨基嘧啶(20),使用硼酸作为催化剂的化合物19A-f和17克-1-的进一步反应,得到所需的磺酰胺羧酰胺衍生物21A-Q以优良产率。的化合物中他们的分析级进行分离,使用FTIR,1H-NMR,13C-NMR和HRMS表征。体外驱虫药的研究表明,所有的合成的化合物具有驱虫特性。相比10分钟为阿苯达唑化合物21A-C,E,G,m和p显示出15,19,14,18,19,分别为19和18分钟,平均瘫痪倍,在100毫克ML-1。相比于阿苯达唑13分钟的化合物21A-C,G和M具有18,24,16,20和25分钟平均死亡次,分别在100毫克ML-1。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号